LexDanaLexDanabeta
Inventor

FRANCIS JOSEPH CARR

Inventor
GB

Overview

8→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 8 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
C12NMicroorganisms or enzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12YEnzymes9%
PatentTitleYear
12,116,409Antibody specific for CD22 and methods of use thereof202411,891,452Anti-kit antibodies and uses thereof202411,884,734Anti-MET antibodies and methods of use thereof202411,866,509Humanized antibodies against CEACAM1202411,712,477Compositions and methods for immunotherapy202311,485,792Antibodies, uses thereof and conjugates thereof202211,427,647Polynucleotides encoding humanized antibodies against CEACAM1202211,236,169Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to FAMEWAVE LTD (2)· patent assignee history
2022Patents assigned to POLYTHERICS LTD (1)· patent assignee history
2022–2024Based in GB· patent location history
2023Patents assigned to NEXIMMUNE INC (1)· patent assignee history
2023Based in US· patent location history
2024Patents assigned to CELLDEX THERAPEUTICS INC (2)· patent assignee history
2024Patents assigned to REDWOOD BIOSCIENCE INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CELLDEX THERAPEUTICS INC22024
FAMEWAVE LTD22022–2024
NEXIMMUNE INC12023
POLYTHERICS LTD12022
REDWOOD BIOSCIENCE INC12024
Locations
LocationPatentsSpan
GB72022–2024
US12023